New US research may have important implications for both diabetes and osteoporosis patients
New US research may have important implications for both diabetes and osteoporosis patients.
A study in mice found that the breakdown of old bone to make way for new bone growth helps to keep a healthy level of glucose in the blood with a hormone called osteocalcin apparently the link. Further tests on osteocalcin and glucose levels in a small group of patients with a genetic defect in their bone turnover supported the initial findings in mice.
An important consequence of the finding for Medical ID wearers is that bone-strengthening drugs used in conditions such as osteoporosis may interfere with this process and cause problems with blood sugar.
Type 2 diabetes is the most common form of the condition and is caused when the body no longer properly responds to insulin leading to out of control blood sugar. The results suggest that for some people, diabetes may be triggered by changes in the skeleton.
Dr Victoria King, head of research at Diabetes UK, said: "The research is interesting and this area of investigation could open up the possibility of more targets for drugs to treat or prevent type 2 diabetes."